TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20177766

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Self-management
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Combined exercise and self-management
Number of subjects: 254
Study: 18319347

Group type: EXPERIMENTAL
Intervention: Open shoulder stabilization (n = 24)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Arthroscopic shoulder stabilization (n = 24)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both surgical groups (open and arthroscopic)
Number of subjects: 48
Study: 15781736

Group type: EXPERIMENTAL
Intervention: Nesiritide (FDA-approved doses < or =0.03 microg x kg(‐1) x min(‐1))
Number of subjects: 1269

Group type: EXPERIMENTAL
Intervention: Nesiritide (any dose up to 0.06 microg x kg(‐1) x min(‐1))
Number of subjects: 1269

Group type: EXPERIMENTAL
Intervention: Low-dose nesiritide (< or =0.015 microg x kg(‐1) x min(‐1))
Number of subjects: 1269

Group type: EXPERIMENTAL
Intervention: Nesiritide (FDA-approved doses)
Number of subjects: 1269

Group type: COMPARATOR
Intervention: Any control therapy (including non-inotrope- and inotrope-based therapies)
Number of subjects: 1269
Study: 12861130

Group type: EXPERIMENTAL
Intervention: Presacral neurectomy (group B)
Number of subjects: 141

Group type: COMPARATOR
Intervention: No presacral neurectomy (group A)
Number of subjects: 141
Study: 10710753

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8663853

Group type: EXPERIMENTAL
Intervention: Anti-TNF-alpha Fab
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control solution
Number of subjects: 49
Study: 1800105

Group type: EXPERIMENTAL
Intervention: Four units of alcohol (95 ml of 40% spirit)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 6479183

Group type: EXPERIMENTAL
Intervention: Dihydralazine (25 mg i.v.)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Dihydralazine (100 mg oral)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Dihydralazine (i.v. and orally)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Dihydralazine (20 mg day‐1 oral)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 31485809

Group type: EXPERIMENTAL
Intervention: Pre-incisional nefopam (20 mg before skin incision)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Post-incisional nefopam (20 mg at 1 h after incision)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Both groups received saline at different times (Group 1: saline before incision, Group 2: saline after incision)
Number of subjects: 150
Study: 29419934

Group type: EXPERIMENTAL
Intervention: Nafamostat mesilate (NM) at 0.5 mg/kg/h during IHD for 5 hours
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nafamostat mesilate (NM) at 0.25 mg/kg/h during IHD
Number of subjects: 18

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH) during IHD
Number of subjects: 18
Study: 26857683

Group type: EXPERIMENTAL
Intervention: Nurse-led intervention programme including one initial session and six group sessions focused on self-management of pain, healthy behaviours, and educational interventions.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified, but implied to be standard care or no intervention.
Number of subjects: 0
Study: 24309219

Group type: EXPERIMENTAL
Intervention: Oral ibuprofen, 800 mg given 60-90 min preprocedure
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Intramuscular ketorolac, 60 mg given 30-60 min preprocedure
Number of subjects: 94
Study: 22390958

Group type: EXPERIMENTAL
Intervention: Ortho-k lenses fitted with computer assisted system
Number of subjects: 51
Study: 19765954

Group type: EXPERIMENTAL
Intervention: L-glutamine (0.5 g kg(‐1) d(‐1))
Number of subjects: 30

Group type: COMPARATOR
Intervention: Calcium caseinate
Number of subjects: 30
Study: 18380208

Group type: EXPERIMENTAL
Intervention: Hydrocortisone butyrate 0.1% lotion
Number of subjects: 284

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 284
Study: 15782288

Group type: EXPERIMENTAL
Intervention: Rosa roxburghii supplementation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 11792135

Group type: EXPERIMENTAL
Intervention: Pravastatin, 40 mg daily
Number of subjects: 19768

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19768
Study: 10088589

Group type: EXPERIMENTAL
Intervention: 7-day/week program
Number of subjects: 113

Group type: COMPARATOR
Intervention: 6-day/week program
Number of subjects: 113
Study: 7670782

Group type: EXPERIMENTAL
Intervention: GTN patches (0.2 mg/h)
Number of subjects: 42
Study: 2188276

Group type: EXPERIMENTAL
Intervention: Aniracetam 1 g daily for 3 months
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo for 3 months
Number of subjects: 44
Study: 7148737

Group type: EXPERIMENTAL
Intervention: 200 micrograms of inorganic chromium as chromic chloride
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo tablet
Number of subjects: 76

Group type: COMPARATOR
Intervention: Nonsupplemented normal free-living subjects
Number of subjects: 76
Study: 31997129

Group type: EXPERIMENTAL
Intervention: Stress group
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 101
Study: 31740368

Group type: EXPERIMENTAL
Intervention: Colchicine 0.6 mg twice daily for 3 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 28587649

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) plus standardised medical care (SMC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standardised medical care (SMC) alone
Number of subjects: 0
Study: 26040499

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg subcutaneously every 6 months
Number of subjects: 3420

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3420
Study: 23522532

Group type: EXPERIMENTAL
Intervention: Buccal infiltration of 1.8 mL 4% articaine hydrochloride with 1:100,000 adrenaline at the canine and first molar
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Buccal infiltration at the second molar
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Injections at adjacent sites (canine and first molar)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Injections at different sites of the mandible
Number of subjects: 22
Study: 22142711

Group type: EXPERIMENTAL
Intervention: Foot orthosis and short-foot exercise (FOSF)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Foot orthosis (FO)
Number of subjects: 28
Study: 19861631

Group type: EXPERIMENTAL
Intervention: Iatrogenic hookworm infection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17823909

Group type: EXPERIMENTAL
Intervention: Dietary advice for weight reduction
Number of subjects: 21

Group type: COMPARATOR
Intervention: General healthy eating booklet
Number of subjects: 21
Study: 15753142

Group type: EXPERIMENTAL
Intervention: Vitamin E supplements
Number of subjects: 0
Study: 11413894

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy (specific drugs not mentioned)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 9503310

Group type: EXPERIMENTAL
Intervention: Wright card
Number of subjects: 44

Group type: COMPARATOR
Intervention: Teller card
Number of subjects: 44
Study: 8061095

Group type: COMPARATOR
Intervention: Control arm of a randomized controlled trial of a vaginal contraceptive sponge
Number of subjects: 163
Study: 2725119

Group type: EXPERIMENTAL
Intervention: Nicotine dose adapted to daily cigarette consumption (n = 51)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standardized nicotine dose (n = 49)
Number of subjects: 100
Study: 1101847

Group type: EXPERIMENTAL
Intervention: Amitriptyline hydrochloride
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Thioridazine
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control group (neurotic patients)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Control group (psychotic patients)
Number of subjects: 225
Study: 30417593

Group type: EXPERIMENTAL
Intervention: 3-month theory-informed intervention (online video, telephone call, two text messages)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 76
Study: 29151484

Group type: EXPERIMENTAL
Intervention: Glucosamine (3000 mg/day for 4 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no glucosamine)
Number of subjects: 20
Study: 26485913

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) group with transcutaneous acupoint electrical stimulation (TAES) combined with dexmedetomidine
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group with dexmedetomidine only
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) group with TAES combined with dexmedetomidine
Number of subjects: 108
Study: 23702674

Group type: EXPERIMENTAL
Intervention: Medifoam H
Number of subjects: 66

Group type: COMPARATOR
Intervention: DuoDERM
Number of subjects: 66
Study: 21477383

Group type: EXPERIMENTAL
Intervention: Probiotic (minimum 1 × 10^9 Lactobacillus fermentum (PCC®) per day)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 18022173

Group type: EXPERIMENTAL
Intervention: Aspirin (300 mg/day)
Number of subjects: 945

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 945

Group type: EXPERIMENTAL
Intervention: Folate (0.5 mg/day)
Number of subjects: 945
Study: 17561800

Group type: EXPERIMENTAL
Intervention: Internet group (n = 32)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (n = 25)
Number of subjects: 57
Study: 15230508

Group type: EXPERIMENTAL
Intervention: Dutch Heart Health Community Intervention
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Control region
Number of subjects: 1200
Study: 11840583

Group type: EXPERIMENTAL
Intervention: oral midazolam, 0.2 mg/kg as anesthetic premedication
Number of subjects: 88

Group type: COMPARATOR
Intervention: saline (oral normal saline as premedication)
Number of subjects: 88
Study: 9512243

Group type: EXPERIMENTAL
Intervention: Human follicular fluid (hFF) from endometriosis patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Human follicular fluid (hFF) from tubal factor patients
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Human follicular fluid (hFF) from male factor patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Earle's balanced salt solution (control)
Number of subjects: 30
Study: 8154410

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1, 20 ng/kg/min for 6 hours
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 15

Group type: COMPARATOR
Intervention: Prostaglandin E1 and Placebo
Number of subjects: 15
Study: 3401524

Group type: EXPERIMENTAL
Intervention: 0.75 ml/kg of ethanol
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 1.1 ml/kg of ethanol
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 31077827

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg twice daily (induction studies)
Number of subjects: 1157

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 or 10 mg twice daily (maintenance study)
Number of subjects: 1157

Group type: EXPERIMENTAL
Intervention: Tofacitinib (various dosages)
Number of subjects: 1157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1157
Study: 29405274

Group type: EXPERIMENTAL
Intervention: Gemcitabine chemotherapy (1000 mg/m2, administered on days 1, 8, and 15 every 4 weeks for six cycles)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Gemcitabine chemotherapy
Number of subjects: 225
Study: 26804729

Group type: EXPERIMENTAL
Intervention: Fluorescence quantity measurement on the cheek
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fluorescence quantity measurement on the chin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fluorescence quantity
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fluorescence measurements on the chin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Fluorescence measurements on the cheek
Number of subjects: 24
Study: 25062592

Group type: EXPERIMENTAL
Intervention: Family-focused therapy for individuals at clinical high risk (FFT-CHR), 18 sessions over 6 months
Number of subjects: 129

Group type: COMPARATOR
Intervention: Enhanced care (EC), 3 sessions of family psychoeducation
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Family-focused therapy for individuals at clinical high risk (FFT-CHR)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Enhanced care (EC)
Number of subjects: 129
Study: 22150341

Group type: EXPERIMENTAL
Intervention: 5% sodium fluoride (NaF) varnish
Number of subjects: 379

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 379
Study: 20547106

Group type: EXPERIMENTAL
Intervention: Adjunctive levetiracetam (LEV) 20‐60mg/kg/day
Number of subjects: 98
Study: 18993165

Group type: EXPERIMENTAL
Intervention: L-Carnitine (2 g/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 16076146

Group type: EXPERIMENTAL
Intervention: 250 g raw purple carrots (463 micromol of anthocyanins: 400 micromol acylated, 63 micromol nonacylated)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 250 g cooked purple carrots (357 micromol of anthocyanins: 308.5 micromol acylated, 48.5 micromol nonacylated)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 500 g cooked purple carrots (714 micromol of anthocyanins: 617 micromol acylated, 97 micromol nonacylated)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acylated anthocyanins
Number of subjects: 0
Study: 11818758

Group type: EXPERIMENTAL
Intervention: ProSeal Laryngeal Mask Airway (PLMA)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Classic Laryngeal Mask Airway (LMA)
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Both PLMA and LMA
Number of subjects: 384
Study: 10759325

Group type: EXPERIMENTAL
Intervention: Habit reversal using a similar competing response
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Habit reversal using a dissimilar competing response
Number of subjects: 26

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 26
Study: 8748431

Group type: EXPERIMENTAL
Intervention: Fluoxetine, 20 mg/day
Number of subjects: 671
Study: 1827284

Group type: EXPERIMENTAL
Intervention: Pefloxacin plus vancomycin (PV)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Gentamicin, colistin sulphate and vancomycin (GCV)
Number of subjects: 150
Study: 7432323

Group type: EXPERIMENTAL
Intervention: High doses of immunoglobulins (Ig)
Number of subjects: 218

Group type: COMPARATOR
Intervention: None (Control group)
Number of subjects: 218
Study: 31344051

Group type: EXPERIMENTAL
Intervention: General Anaesthesia (GA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Integrated Anaesthesia (IA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regional Anaesthesia (RA)
Number of subjects: 0
Study: 28025662

Group type: EXPERIMENTAL
Intervention: Live-high Train-high (LH-TH)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Live-high (LH)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study: 24491403

Group type: EXPERIMENTAL
Intervention: Heart Age tool
Number of subjects: 3153

Group type: EXPERIMENTAL
Intervention: Framingham REGICOR
Number of subjects: 3153

Group type: COMPARATOR
Intervention: Control (conventional medical advice)
Number of subjects: 3153
Study: 23370492

Group type: EXPERIMENTAL
Intervention: Visual-Visual modality match condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Auditory-Visual modality mismatch condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modality manipulation
Number of subjects: 0
Study: 21326220

Group type: EXPERIMENTAL
Intervention: BCAA (branched-chain amino acids)
Number of subjects: 116

Group type: COMPARATOR
Intervention: MDX (maltodextrin)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: BCAA
Number of subjects: 116
Study: 19374041

Group type: EXPERIMENTAL
Intervention: UrgoCell Start
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Urgotul Start
Number of subjects: 0
Study: 17473825

Group type: EXPERIMENTAL
Intervention: Paclitaxel
Number of subjects: 160
Study: 15084995

Group type: EXPERIMENTAL
Intervention: Baby Boot Camp
Number of subjects: 91

Group type: COMPARATOR
Intervention: Traditional childbirth education program
Number of subjects: 91
Study: 12596613

Group type: EXPERIMENTAL
Intervention: Tracheal detecting-bulb (TDB)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Capnography
Number of subjects: 400
Study: 9665110

Group type: EXPERIMENTAL
Intervention: Beta-carotene (50 mg on alternate days for an average of 12 years)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-carotene
Number of subjects: 0
Study: 7666075

Group type: EXPERIMENTAL
Intervention: Vinorelbine plus cisplatin
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Vindesine plus cisplatin
Number of subjects: 612

Group type: COMPARATOR
Intervention: Vinorelbine
Number of subjects: 612
Study: 2503432

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 20 mg or more, oral administration three or four times a day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) during maintenance therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) under ergometric exercise conditions
Number of subjects: 0
Study: 356350

Group type: EXPERIMENTAL
Intervention: SL 25 (active substance)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 34
Study: 29166829

Group type: EXPERIMENTAL
Intervention: Rucaparib
Number of subjects: 0
Study: 28131786

Group type: EXPERIMENTAL
Intervention: Buparlisib plus paclitaxel
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo plus paclitaxel
Number of subjects: 158
Study: 26924018

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (2 mA, 20 min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham tDCS (2 mA, 20 min)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2 mA, 20 min)
Number of subjects: 0
Study: 24884613

Group type: EXPERIMENTAL
Intervention: Electrolyte-branched chain amino acid (EA) beverage
Number of subjects: 20

Group type: COMPARATOR
Intervention: Electrolyte-carbohydrate (EC) beverage
Number of subjects: 20

Group type: COMPARATOR
Intervention: Flavored water (FW) beverage
Number of subjects: 20
Study: 22009509

Group type: EXPERIMENTAL
Intervention: Mifepristone (200 mg) followed by buccal misoprostol (800 µg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Buccal misoprostol (800 µg only)
Number of subjects: 100
Study: 19545341

Group type: EXPERIMENTAL
Intervention: Transvenous (TV) leads
Number of subjects: 78

Group type: COMPARATOR
Intervention: Epicardial (Epi) leads
Number of subjects: 78
Study: 17973181

Group type: EXPERIMENTAL
Intervention: myofeedback with ergonomic counseling (Mfb/EC)
Number of subjects: 79

Group type: COMPARATOR
Intervention: ergonomic counseling alone (EC)
Number of subjects: 79
Study: 15134766

Group type: EXPERIMENTAL
Intervention: Arousal following a saccade
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control conditions employed in the experiments
Number of subjects: 0
Study: 11549432

Group type: EXPERIMENTAL
Intervention: Autologous peripheral blood stem cell transplantation (PBSCT)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Autologous bone marrow transplantation (ABMT)
Number of subjects: 91
Study: 9576155

Group type: EXPERIMENTAL
Intervention: Mechanical clamp compression
Number of subjects: 778

Group type: COMPARATOR
Intervention: Hand applied pressure
Number of subjects: 778
Study: 7820333

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg/day for 7 days
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fluconazole 100 mg after omeprazole treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fluconazole 100 mg before omeprazole treatment
Number of subjects: 12
Study: 3416848

Group type: EXPERIMENTAL
Intervention: Fasted (F) condition
Number of subjects: 6

Group type: COMPARATOR
Intervention: Normal-diet (ND) condition
Number of subjects: 6
Study: 29945656

Group type: EXPERIMENTAL
Intervention: Automated recruitment and randomisation method
Number of subjects: 12681

Group type: COMPARATOR
Intervention: Manual recruitment and randomisation method
Number of subjects: 12681
Study: 28212163

Group type: EXPERIMENTAL
Intervention: Concurrent multiple organ dysfunction syndrome (MODS)
Number of subjects: 2449

Group type: EXPERIMENTAL
Intervention: New multiple organ dysfunction syndrome (MODS)
Number of subjects: 2449
Study: 25913848

Group type: EXPERIMENTAL
Intervention: High MUFA shake (95 g)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: High SFA shake (95 g)
Number of subjects: 32
Study: 23680708

Group type: EXPERIMENTAL
Intervention: Standard triple therapy with concomitant probiotic (Bifidus infantis)
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: Standard triple therapy with pre-treatment of probiotic (Bifidus infantis for 2 weeks)
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: Sequential therapy with concomitant probiotic (Bifidus infantis)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Traditional standard triple therapy (control group)
Number of subjects: 377
Study: 21305611

Group type: EXPERIMENTAL
Intervention: Swedish-style snus (SS)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Nicotine-containing lozenge (NL)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo snus (PS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo lozenge (PL)
Number of subjects: 15
Study: 18299468

Group type: EXPERIMENTAL
Intervention: Abdominoplasty
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Bilateral breast reduction
Number of subjects: 49

Group type: COMPARATOR
Intervention: Carpal tunnel syndrome release
Number of subjects: 49
Study: 17162243

Group type: EXPERIMENTAL
Intervention: Serum insulin
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: HOMA-IR
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Glucose
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Comparison of highest vs lowest quartiles for each biomarker
Number of subjects: 29
Study: 12975757

Group type: EXPERIMENTAL
Intervention: Tobacco abstinence
Number of subjects: 0
Study: 16279825

Group type: EXPERIMENTAL
Intervention: 400 mg ibuprofen
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 550 mg naproxen sodium
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60